中泰化學(002092.SZ):擬公開掛牌方式轉讓所持天泰纖維35.07%股權
格隆匯11月29日丨中泰化學(002092.SZ)公佈,天泰纖維系公司參股公司,公司持有其35.07%股權,基於公司戰略發展規劃和經營需要,為優化資產結構和產業佈局,公司擬通過公開掛牌方式轉讓持有的天泰纖維35.07%股權,以天泰纖維2021年6月30日淨資產評估值為定價參考依據,在產權交易所的掛牌底價為人民幣3.05億元,具體交易價格將按公開掛牌競價結果確定。
本次掛牌轉讓天泰纖維35.07%股權符合公司戰略發展和經營需要,有利於優化公司資產結構和產業佈局,本次交易不會對公司正常生產經營產生不利影響,不存在損害公司及全體股東利益的情形。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.